171 related articles for article (PubMed ID: 37300745)
41. Association of
Rahman N; Zakiullah ; Jan A; Saeed M; Khan MA; Parveen Z; Iqbal J; Ali S; Shah WA; Akbar R; Khuda F
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980959
[TBL] [Abstract][Full Text] [Related]
42. New single nucleotide polymorphisms (SNPs) in homologous recombination repair genes detected by microarray analysis in Polish breast cancer patients.
Romanowicz H; Strapagiel D; Słomka M; Sobalska-Kwapis M; Kępka E; Siewierska-Górska A; Zadrożny M; Bieńkiewicz J; Smolarz B
Clin Exp Med; 2017 Nov; 17(4):541-546. PubMed ID: 27900500
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients.
Rashid MU; Zaidi A; Torres D; Sultan F; Benner A; Naqvi B; Shakoori AR; Seidel-Renkert A; Farooq H; Narod S; Amin A; Hamann U
Int J Cancer; 2006 Dec; 119(12):2832-9. PubMed ID: 16998791
[TBL] [Abstract][Full Text] [Related]
44. Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.
Cavallone L; Arcand SL; Maugard C; Ghadirian P; Mes-Masson AM; Provencher D; Tonin PN
BMC Cancer; 2008 Apr; 8():96. PubMed ID: 18402691
[TBL] [Abstract][Full Text] [Related]
45. MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent.
Yarden RI; Friedman E; Metsuyanim S; Olender T; Ben-Asher E; Papa MZ
Breast Cancer Res Treat; 2008 Oct; 111(3):497-504. PubMed ID: 18026875
[TBL] [Abstract][Full Text] [Related]
46. Identification of Variants (rs11571707, rs144848, and rs11571769) in the
Dobbin EAF; Medeiros JAG; Costa MSCR; Rodrigues JCG; Guerreiro JF; Kroll JE; Souza SJ; de Assumpção PP; Ribeiro-Dos-Santos Â; Santos SEBD; Burbano RMR; Fernandes MR; Santos NPCD
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33499154
[TBL] [Abstract][Full Text] [Related]
47. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G
Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188
[TBL] [Abstract][Full Text] [Related]
48. Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.
Figueiredo JC; Brooks JD; Conti DV; Poynter JN; Teraoka SN; Malone KE; Bernstein L; Lee WD; Duggan DJ; Siniard A; Concannon P; Capanu M; Lynch CF; Olsen JH; Haile RW; Bernstein JL
Breast Cancer Res Treat; 2011 Jun; 127(3):819-29. PubMed ID: 21161372
[TBL] [Abstract][Full Text] [Related]
49. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
[TBL] [Abstract][Full Text] [Related]
50. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age.
Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL
BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450
[TBL] [Abstract][Full Text] [Related]
51. BRCA1 and TP53 Gene-Mutations: Family Predisposition and Radioecological Risk of Developing Breast Cancer.
Apsalikov B; Manambaeva Z; Ospanov E; Massabayeva M; Zhabagin K; Zhagiparova Z; Maximov V; Voropaeva E; Apsalikov K; Belikhina T; Abdrahmanov R; Cherepkova E; Tanatarov S; Massadykov A; Urazalina N
Asian Pac J Cancer Prev; 2016; 17(8):4059-62. PubMed ID: 27644661
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.
Erturk E; Cecener G; Polatkan V; Gokgoz S; Egeli U; Tunca B; Tezcan G; Demirdogen E; Ak S; Tasdelen I
Asian Pac J Cancer Prev; 2014; 15(19):8319-24. PubMed ID: 25339023
[TBL] [Abstract][Full Text] [Related]
53. BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.
Cherbal F; Bakour R; Adane S; Boualga K; Benais-Pont G; Maillet P
Dis Markers; 2010; 28(6):377-84. PubMed ID: 20683152
[TBL] [Abstract][Full Text] [Related]
54. Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations.
Kim J; Jeong K; Jun H; Kim K; Bae JM; Song MG; Yi H; Park S; Woo GU; Lee DW; Kim TY; Lee KH; Im SA
Hum Genomics; 2023 Jan; 17(1):2. PubMed ID: 36604691
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.
Konecny M; Milly M; Zavodna K; Weismanova E; Gregorova J; Mlkva I; Ilencikova D; Kausitz J; Bartosova Z
Breast Cancer Res Treat; 2011 Feb; 126(1):119-30. PubMed ID: 21203900
[TBL] [Abstract][Full Text] [Related]
56. The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Garcia AI; Cox DG; Barjhoux L; Verny-Pierre C; Barnes D; ; Antoniou AC; Stoppa-Lyonnet D; Sinilnikova OM; Mazoyer S
Hum Mutat; 2011 Sep; 32(9):1004-7. PubMed ID: 21591024
[TBL] [Abstract][Full Text] [Related]
57. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
[TBL] [Abstract][Full Text] [Related]
58. [BRCA1 and BRCA2 gene mutations of familial breast cancer from Shanghai in China].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):27-31. PubMed ID: 16456781
[TBL] [Abstract][Full Text] [Related]
59. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
Walsh T; Casadei S; Coats KH; Swisher E; Stray SM; Higgins J; Roach KC; Mandell J; Lee MK; Ciernikova S; Foretova L; Soucek P; King MC
JAMA; 2006 Mar; 295(12):1379-88. PubMed ID: 16551709
[TBL] [Abstract][Full Text] [Related]
60. Genetic susceptibility to oral cancer due to combined effects of GSTT1, GSTM1 and CYP1A1 gene variants in tobacco addicted patients of Pashtun ethnicity of Khyber Pakhtunkhwa province of Pakistan.
Zakiullah ; Ahmadullah ; Khisroon M; Saeed M; Khan A; Khuda F; Ali S; Javed N; Ovais M; Masood N; Khalil NK; Ismail M
Asian Pac J Cancer Prev; 2015; 16(3):1145-50. PubMed ID: 25735346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
